PHASE-II STUDY OF TENIPOSIDE IN ADENOCARCINOMA OF THE LUNG

被引：3

作者：

SORENSEN, JB ^{[1
]}

BACH, F ^{[1
]}

DOMBERNOWSKY, P ^{[1
]}

HANSEN, HH ^{[1
]}

机构：

[1] UNIV COPENHAGEN,HERLEV HOSP,DK-2730 HERLEV,DENMARK

来源：

CANCER CHEMOTHERAPY AND PHARMACOLOGY | 1991年 / 27卷 / 06期

关键词：

D O I：

10.1007/BF00685166

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

A total of 26 evaluable patients with previously untreated, non-resectable adenocarcinoma of the lung were given 80 mg/m2 i.v. teniposide daily for 5 days every 3 weeks. Three partial responses (11%) were obtained that lasted for 12, 11 and 32 weeks, respectively. Leucopenia was the dose-limiting side effect, with WBC counts of < 2 x 10(9)/l being observed in 42% of patients, resulting in one septic death. At the dose and schedule used in the present study, teniposide showed only limited activity in adenocarcinoma of the lung.

引用

页码：487 / 489

页数：3

共 50 条

[31] HIGH-DOSE MEDROXYPROGESTERONE ACETATE IN PATIENTS WITH RENAL ADENOCARCINOMA AND MEASURABLE LUNG METASTASES - A PHASE-II STUDY
KJAER, M
FREDERIKSEN, PL
CANCER TREATMENT REPORTS, 1986, 70 (03): : 431 - 432
[32] MISTELTOE (ISCADOR) THERAPY IN STAGE IV RENAL ADENOCARCINOMA - A PHASE-II STUDY IN PATIENTS WITH MEASURABLE LUNG METASTASES
KJAER, M
ACTA ONCOLOGICA, 1989, 28 (04) : 489 - 494
[33] TENIPOSIDE IN ADVANCED BREAST-CANCER - A PHASE-II TRIAL IN PATIENTS WITH NO PRIOR CHEMOTHERAPY
NIELSEN, D
BOAS, J
ENGELHOLM, SA
HANSEN, OP
DOMBERNOWSKY, P
ANNALS OF ONCOLOGY, 1992, 3 (05) : 377 - 378
[34] TENIPOSIDE IN EPITHELIAL OVARIAN-CARCINOMA - A PHASE-II TRIAL OF THE GYNECOLOGIC ONCOLOGY GROUP
MUSS, H
BUNDY, BN
DISAIA, PJ
TWIGGS, LB
CANCER TREATMENT REPORTS, 1986, 70 (10): : 1231 - 1232
[35] UNEXPECTED HIGH TOXICITY IN A PHASE-II STUDY OF TENIPOSIDE (VM-26) IN ELDERLY PATIENTS WITH UNTREATED SMALL CELL LUNG-CANCER (SCLC)
CERNY, T
PEDRAZZINI, A
JOSS, RA
BRUNNER, KW
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1988, 24 (11): : 1791 - 1794
[36] PHASE-II STUDY OF CYCLOPHOSPHAMIDE, ADRIAMYCIN, AND CIS-DICHLORODIAMMINEPLATINUM(II) BY INFUSION IN PATIENTS WITH ADENOCARCINOMA AND LARGE CELL-CARCINOMA OF THE LUNG
EAGAN, RT
FRYTAK, S
CREAGAN, ET
INGLE, JN
KVOLS, LK
COLES, DT
CANCER TREATMENT REPORTS, 1979, 63 (9-10): : 1589 - 1591
[37] PHASE-II TRIAL OF MENOGARIL IN METASTATIC ADENOCARCINOMA OF THE PROSTATE
TAYLOR, SA
BLUMENSTEIN, BA
STEPHENS, RL
CRAWFORD, ED
PISTONE, B
HILL, JB
INVESTIGATIONAL NEW DRUGS, 1994, 12 (01) : 67 - 70
[38] PHASE-II TRIAL OF PIROXANTRONE IN METASTATIC GASTRIC ADENOCARCINOMA
PAZDUR, R
BREADY, B
SCALZO, AJ
BRANDOF, JE
CLOSE, DR
KOLBYE, S
WINN, RJ
INVESTIGATIONAL NEW DRUGS, 1994, 12 (03) : 263 - 265
[39] PHASE-II TRIAL OF DIAZIQUONE IN ADVANCED RENAL ADENOCARCINOMA
HANSEN, M
GALLMEIER, WM
VERMORKEN, J
HOLDENER, E
HANSEN, HH
RENARD, J
ROZENCWEIG, M
CANCER TREATMENT REPORTS, 1984, 68 (7-8): : 1055 - 1056
[40] PHASE-II TRIAL OF CARBOPLATIN AND VINBLASTINE IN ADENOCARCINOMA OF THE STOMACH
GINN, D
KELSEN, D
EISENBERGER, M
HEELAN, R
MAGILL, G
INVESTIGATIONAL NEW DRUGS, 1990, 8 (03) : 321 - 324

← 1 2 3 4 5 →